Vir Biotechnology is now a two-engine company, with major pharma partnerships and a fully enrolled hepatitis delta phase 3 ...

Lund University. For most of his career as a researcher, Lars Björck has sought to understand how bacteria manage to evade ...

How this list was built Scope. Every biotech initial public offering with a first trading day between 1 January and 24 ...

Treatment options for patients with relapsed/refractory follicular lymphoma have expanded rapidly. CD19-directed CAR T-cell therapies are approved in the third-line setting and beyond, and CD20 x CD3 ...

Researchers at Washington University School of Medicine in St. Louis have developed a potential antibody-based approach to ...

There is no treatment available today to stop the death of brain cells in neurodegenerative diseases known as tauopathies, ...

Antibodies made by the immune system can sometimes target human brain cells, producing psychiatric symptoms. Researchers aim ...

The findings in the journal Immunity provide a new target for developing a vaccine against P. vivax, the most wide spread ...

When reading through medical records, I sometimes encounter stories that have nothing to do with tests or medications. How ...

When I finish explaining a treatment, silence sometimes falls over the examination room. The patient stares at a point on the ...

FDA movement of peptides toward 503A bulks listing advanced despite internal scientific objections citing absent human ...

The same drugs powerful enough to kill cancer cells can also damage healthy tissue. UC Irvine researchers are trying to ...